You searched for Humanized antibody - Page 38 of 44

Interview 27 Mar 2017

Meet one of the Most Successful Biotech Entrepreneurs in the UK

…Molecular Genetics at Leicester, and then a postdoc at Bath on antibody engineering, before moving to Cambridge to work at the GURDON Institute. It was during his postdoc and his…

March 27, 2017 - 7 minutesmins - By Philip Hemme

News and Trends 21 Feb 2023

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

…Maraganore, chair of Hemab’s board of directors. About HMB-001 HMB-001 is bispecific antibody that binds and stabilizes endogenous factor VIIa (FVIIa) with one antibody arm and TLT-1 on activated platelets…

February 21, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 27 Apr 2016

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase IIb/III trial for a muscle disease (sIBM), conducted by Novartis. Sad news for Novartis and…

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

…commercial milestone payments up to $637 million plus mid-single to low double-digit royalties on sales. About Affibody molecules Affibody molecules are a novel class of antibody mimetics with characteristics surpassing…

March 8, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 15 May 2018

Here Are 10 of the Hottest Biotech Hubs in Europe

…Planegg. Right there is one of Europe’s largest biotechs: MorphoSys, a billion-euro biotech that develops antibody therapies. The city is also home to Medigene, which develops T cell receptor technology…

May 15, 2018 - 10 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Jan 2025

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

…only the three main types but also additional subtypes,” said Rosenthal. Star Therapeutics and VGA039, the new wave in von Willebrand disease? “VGA039 is a first-in-class antibody therapy with a…

January 9, 2025 - 7 minutesmins - By Jules Adam

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

…enhancements that come with our approach.” Clinical-stage assets HI-Bio’s clinical-stage assets include felzartamab, an anti-CD38 antibody, and HIB210, an anti-C5aR1 antibody. Felzartamab targets a protein expressed on the surface of…

November 1, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…Founded: 2019 Alchemab Therapeutics is a biotechnology company working on harnessing the power of the immune system to create the next generation of antibody therapeutics for hard-to-treat diseases that do…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

…will be used to finance an ongoing phase 1/2 trial of a bispecific antibody treatment for the rare bleeding condition Glanzmann thrombasthenia in addition to the launch of a phase…

March 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 16 Nov 2020

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

…deal’s terms, Affimed will receive €51M upfront to license to Roivant a preclinical-stage antibody drug for several undisclosed types of cancer. Roivant will handle the program once Affimed completes preclinical…

November 16, 2020 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

…studies. However, commercializing treatments for viral infections like Covid-19 won’t be plain sailing. For example, Ethris and the Swiss antibody company Neurimmune discontinued the joint development of mRNA treatments encoding…

February 1, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 26 May 2023

Could new Lyme disease tests help to prevent chronic infection?

…order to create a better Lyme disease test. Dr Abdo Alnabulsi, chief executive officer (CEO) of EpitogenX, stated: “We are working on a serology based antibody test for the detection…

May 26, 2023 - 10 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Meet one of the Most Successful Biotech Entrepreneurs in the UK

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

Affibody and Chiesi Group to develop treatments for respiratory diseases

Here Are 10 of the Hottest Biotech Hubs in Europe

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

Human Immunology Biosciences launches with $120M

10 biotech companies making a difference in rare diseases

The biggest private biotech investments in February 2023

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Could new Lyme disease tests help to prevent chronic infection?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!